AugmentRx augmentrx.com


Public lists: Pharma Startups (4732)

AugmentRx has developed a tissue bulking agent to treat stress urinary incontinence. The SOLVE injectable product aims to provide a fully viable alternative to slings, surgical procedures and inferior shorter-acting bulking agents. Per AugmentRx, it is bioinert, non-antigenic, non-migratory, permanent, easy-to-inject, and more affordable and aims to provide long-lasting, sustainable tissue volume.

AugmentRx has developed a tissue bulking agent to treat stress urinary incontinence. The SOLVE injectable product aims to provide a fully viable alternative to slings, surgical procedures and inferior shorter-acting bulking agents. Per AugmentRx, it ...Show all

Company (Alive / Active)

Phone: 802-985-8234

Fax:

5224 Shelburne Road
Shelburne, 05482
Vermont, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AugmentRx $0M Nov 30, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AugmentRx Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Biofisica

Duluth, Georgia, United States
Alive / ActiveBiofisica develops and markets products for soft tissue wound healing and tissue regeneration based on an exclusive and technology that uses electrical stimulation and hydro-gel materials.Login to see details

NuPathe

Conshohocken, Pennsylvania, United States
AcquiredNuPathe is a specialty pharmaceutical company developing therapeutic products for the treatment of neurological and psychiatric diseases. NuPathe's product portfolio includes NP101, which will be a transdermal patch for the treatment of acute migraine, and NP201, a long acting injectable implant for the treatment of Parkinson's disease.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)